glp-1 in the brain From metabolism to mind: expanding role of the receptor neurotherapeutics GLP-1 programs the neurovascular landscape:
Description
These coordinated actions on lipid metabolism contribute to steatosis resolution
GLP-1 RAs, such as exenatide and lixisenatide, have shown benefits in addressing the pathology of PD in animal studies and phase II clinical trials, halting progression and delaying worsening of symptoms
This spring has to cope with high forces: Walking
increase IL-10 levels
Worried about GLP-1 side effects like nausea or fatigue
Similar movement was also seen for the C-terminal half of tirzepatide (2.1 measured by the C of I27 P )
